Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
NCT ID: NCT02897271
Last Updated: 2021-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
381 participants
OBSERVATIONAL
2016-08-31
2020-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Primary Eosinophilic Colitis in Symptomatic Patients.
NCT05719727
Contrast-enhanced Ultrasound in Patients With Crohn´s Disease and Food Allergy
NCT05768971
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184
The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
NCT02389075
Fecal Microbiota Transplantation in Pediatric Patients
NCT02108821
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical symptoms of gastrointestinal dysfunction.
* Findings of increased eosinophils on tissue biopsy at the time of diagnosis, before treatment initiated.
* Exclusion of other causes of gastrointestinal eosinophilia.
Exclusion Criteria
* Diagnosis of EoE without another EGID.
* Insufficient medical record or pathology data available to support an EGID diagnosis.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Medical Center, Cincinnati
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Office of Rare Diseases (ORD)
NIH
National Center for Advancing Translational Sciences (NCATS)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc E Rothenberg, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arkansas for Medical Science
Little Rock, Arkansas, United States
Children's Hospital Colorado
Denver, Colorado, United States
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Rare Diseases Clinical Research Network website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-4349
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.